Who
Michael J. Carson
Vice President, Finance
Company insider
Files Form 4 as: Vice President, Finance, Nuvectis Pharma.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $22K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Jan 2023
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 6 Jan 2026filed 9 Jan 2026 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —61,200 at $0.00 | filing |
| 6 Jan 2026filed 9 Jan 2026 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —61,200 at $0.00 | filing |
| 2 Jan 2025filed 3 Jan 2025 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —51,000 at $0.00 | filing |
| 7 Nov 2024filed 8 Nov 2024 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Sold | $22K2,755 at $8.16 | filing |
| 4 Jan 2024filed 8 Nov 2024 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —34,567 at $0.00 | filing |
| 3 Jan 2023filed 8 Nov 2024 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —28,806 at $0.00 | filing |
News
Nuvectis Pharma (NASDAQ:NVCT) Stock Falls 6.8% – Here's WhyNVCT · themarketsdaily.com · 15 Oct 2026
0 headlines in the last 90 days name Michael J. Carson; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.